{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T07:33:16Z","timestamp":1787729596192,"version":"build-2784847793"},"reference-count":75,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Pathology"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.humpath.2020.04.012","type":"journal-article","created":{"date-parts":[[2020,5,11]],"date-time":"2020-05-11T12:03:40Z","timestamp":1589198620000},"page":"83-97","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"special_numbering":"C","title":["Data set for the reporting of pheochromocytoma and paraganglioma: explanations and recommendations of the guidelines from the International Collaboration on Cancer Reporting"],"prefix":"10.1016","volume":"110","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3714-1432","authenticated-orcid":false,"given":"Lester D.R.","family":"Thompson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony J.","family":"Gill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8418-5054","authenticated-orcid":false,"given":"Sylvia L.","family":"Asa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roderick J.","family":"Clifton-Bligh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald R.","family":"de Krijger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8160-3687","authenticated-orcid":false,"given":"Noriko","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Komminoth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ernest E.","family":"Lack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques W.M.","family":"Lenders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo V.","family":"Lloyd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas G.","family":"Papathomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter M.","family":"Sadow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9726-5739","authenticated-orcid":false,"given":"Arthur S.","family":"Tischler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.humpath.2020.04.012_bib1","doi-asserted-by":"crossref","first-page":"e255","DOI":"10.1200\/JOP.2012.000818","article-title":"Closing the quality loop: facilitating improvement in oncology practice through timely access to clinical performance indicators","volume":"9","author":"Srigley","year":"2013","journal-title":"J Oncol Pract"},{"key":"10.1016\/j.humpath.2020.04.012_bib2","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s00428-015-1834-4","article-title":"Does standardised structured reporting contribute to quality in diagnostic pathology? The importance of evidence-based datasets","volume":"468","author":"Ellis","year":"2016","journal-title":"Virchows Arch"},{"key":"10.1016\/j.humpath.2020.04.012_bib3","series-title":"Phaeochromocytoma and Paraganglioma Histopathology Reporting Guide","author":"Tischler","year":"2019"},{"key":"10.1016\/j.humpath.2020.04.012_bib4","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/1471-2288-9-34","article-title":"Extending an evidence hierarchy to include topics other than treatment: revising the Australian 'levels of evidence","volume":"9","author":"Merlin","year":"2009","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/j.humpath.2020.04.012_bib5","series-title":"Carcinoma of the Adrenal Cortex Histopathology Reporting Guide","author":"Giordano","year":"2019"},{"key":"10.1016\/j.humpath.2020.04.012_bib6","first-page":"69","article-title":"Metabologenomics of Phaeochromocytoma and Paraganglioma: An Integrated Approach for Personalised Biochemical and Genetic Testing","volume":"38","author":"Eisenhofer","year":"2017","journal-title":"Clin Biochem Rev"},{"key":"10.1016\/j.humpath.2020.04.012_bib7","doi-asserted-by":"crossref","first-page":"182","DOI":"10.5858\/arpa.2012-0551-OA","article-title":"Protocol for the examination of specimens from patients with pheochromocytomas and extra-adrenal paragangliomas","volume":"138","author":"Mete","year":"2014","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.humpath.2020.04.012_bib8","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/his.13402","article-title":"Pathology and genetics of phaeochromocytoma and paraganglioma","volume":"72","author":"Turchini","year":"2018","journal-title":"Histopathology"},{"key":"10.1016\/j.humpath.2020.04.012_bib9","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/nrendo.2016.185","article-title":"Consensus Statement on next-generation-sequencing-based diagnostic testing of hereditary phaeochromocytomas and paragangliomas","volume":"13","author":"Toledo","year":"2017","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.humpath.2020.04.012_bib10","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.5858\/2008-132-1272-PAEPU","article-title":"Pheochromocytoma and extra-adrenal paraganglioma: updates","volume":"132","author":"Tischler","year":"2008","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.humpath.2020.04.012_bib11","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1210\/jc.2014-1498","article-title":"Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline","volume":"99","author":"Lenders","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.humpath.2020.04.012_bib12","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1007\/s12022-018-9544-5","article-title":"Catecholamine-Synthesizing Enzymes in Pheochromocytoma and Extraadrenal Paraganglioma","volume":"29","author":"Konosu-Fukaya","year":"2018","journal-title":"Endocr Pathol"},{"key":"10.1016\/j.humpath.2020.04.012_bib13","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1056\/NEJMra1806651","article-title":"Pheochromocytoma and Paraganglioma","volume":"381","author":"Neumann","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.humpath.2020.04.012_bib14","series-title":"Tumours of Endocrine Organs","first-page":"183","article-title":"Tumours of the adrenal medulla and extra-adrenal paraganglia: Phaeochromocytoma","author":"Tischler","year":"2017"},{"key":"10.1016\/j.humpath.2020.04.012_bib15","series-title":"Tumours of Endocrine Organs","first-page":"190","article-title":"Tumours of the adrenal medulla and extra-adrenal paraganglia: Extra-adrenal paragangliomas","author":"Kimura","year":"2017"},{"key":"10.1016\/j.humpath.2020.04.012_bib16","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.surg.2007.07.013","article-title":"Needle biopsy of incidentally discovered adrenal masses is rarely informative and potentially hazardous","volume":"142","author":"Quayle","year":"2007","journal-title":"Surgery"},{"key":"10.1016\/j.humpath.2020.04.012_bib17","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1148\/radiology.159.3.3517958","article-title":"Unsuspected pheochromocytoma: risk of blood-pressure alterations during percutaneous adrenal biopsy","volume":"159","author":"Casola","year":"1986","journal-title":"Radiology"},{"key":"10.1016\/j.humpath.2020.04.012_bib18","first-page":"923","article-title":"Pheochromocytoma manifesting with shock presents a clinical paradox: a case report","volume":"157","author":"Ford","year":"1997","journal-title":"CMAJ"},{"issue":"Suppl 1 UCTN","key":"10.1016\/j.humpath.2020.04.012_bib19","first-page":"E447","article-title":"Hypertensive crisis after endoscopic ultrasound-guided fine-needle aspiration of the right adrenal gland","volume":"46","author":"de Vries","year":"2014","journal-title":"Endoscopy"},{"key":"10.1016\/j.humpath.2020.04.012_bib20","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1002\/dc.23696","article-title":"Challenging differential\u00a0diagnosis of an extra-adrenal paraganglioma; the role of\u00a0fine needle aspiration cytology","volume":"45","author":"Ntanasis-Stathopoulos","year":"2017","journal-title":"Diagn Cytopathol"},{"key":"10.1016\/j.humpath.2020.04.012_bib21","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.eururo.2011.03.046","article-title":"Robot-assisted laparoscopic partial adrenalectomy for pheochromocytoma: the National Cancer Institute technique","volume":"60","author":"Asher","year":"2011","journal-title":"Eur Urol"},{"key":"10.1016\/j.humpath.2020.04.012_bib22","doi-asserted-by":"crossref","first-page":"T123","DOI":"10.1530\/ERC-15-0261","article-title":"15 years of paraganglioma: Pathology of pheochromocytoma and paraganglioma","volume":"22","author":"Tischler","year":"2015","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.humpath.2020.04.012_bib23","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1053\/j.anndiagpath.2004.04.008","article-title":"Primary paraganglioma of the lung","volume":"8","author":"Aubertine","year":"2004","journal-title":"Ann Diagn Pathol"},{"key":"10.1016\/j.humpath.2020.04.012_bib24","doi-asserted-by":"crossref","first-page":"T91","DOI":"10.1530\/ERC-15-0268","article-title":"15 years of paraganglioma: Clinical manifestations of paraganglioma syndromes types 1-5","volume":"22","author":"Benn","year":"2015","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.humpath.2020.04.012_bib25","series-title":"AJCC Cancer Staging Manual","author":"Amin","year":"2017"},{"key":"10.1016\/j.humpath.2020.04.012_bib26","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1097\/MED.0000000000000330","article-title":"Malignant pheochromocytoma-paraganglioma: pathogenesis, TNM staging, and current clinical trials","volume":"24","author":"Roman-Gonzalez","year":"2017","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"10.1016\/j.humpath.2020.04.012_bib27","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1097\/00000478-200205000-00002","article-title":"Pheochromocytoma of the Adrenal gland Scaled Score (PASS) to separate benign from malignant neoplasms: a clinicopathologic and immunophenotypic study of 100 cases","volume":"26","author":"Thompson","year":"2002","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2020.04.012_bib28","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/ncpendmet0396","article-title":"Pheochromocytoma: recommendations for clinical practice from the First International Symposium October 2005","volume":"3","author":"Pacak","year":"2007","journal-title":"Nat Clin Pract Endocrinol Metab"},{"key":"10.1016\/j.humpath.2020.04.012_bib29","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1016\/j.ejca.2011.07.016","article-title":"Plasma methoxytyramine: a novel biomarker of metastatic pheochromocytoma and paraganglioma in relation to established risk factors of tumour size, location and SDHB mutation status","volume":"48","author":"Eisenhofer","year":"2012","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.humpath.2020.04.012_bib30","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1007\/s12022-016-9460-5","article-title":"Pathological and Genetic Characterization of Bilateral Adrenomedullary Hyperplasia in a Patient with Germline MAX Mutation","volume":"28","author":"Romanet","year":"2017","journal-title":"Endocr Pathol"},{"key":"10.1016\/j.humpath.2020.04.012_bib31","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/j.neo.2014.09.002","article-title":"Adrenal medullary hyperplasia is a precursor lesion for pheochromocytoma in MEN2 syndrome","volume":"16","author":"Korpershoek","year":"2014","journal-title":"Neoplasia"},{"key":"10.1016\/j.humpath.2020.04.012_bib32","series-title":"Tumors of the Adrenal Glands and Extraadrenal Paraganglia","author":"Lack","year":"2007"},{"key":"10.1016\/j.humpath.2020.04.012_bib33","first-page":"177","article-title":"Adrenal medullary hyperplasia. A morphometric analysis in patients with familial medullary thyroid carcinoma","volume":"83","author":"DeLellis","year":"1976","journal-title":"Am J Pathol"},{"key":"10.1016\/j.humpath.2020.04.012_bib34","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1530\/ERC-13-0494","article-title":"Pathological grading for predicting metastasis in phaeochromocytoma and paraganglioma","volume":"21","author":"Kimura","year":"2014","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.humpath.2020.04.012_bib35","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/1751-2980.12439","article-title":"Clinical value of MRI-detected extramural venous invasion in rectal cancer","volume":"18","author":"Tripathi","year":"2017","journal-title":"J Dig Dis"},{"key":"10.1016\/j.humpath.2020.04.012_bib36","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/S1499-3872(16)60156-X","article-title":"Significance of pathological positive superior mesenteric\/portal venous invasion in pancreatic cancer","volume":"15","author":"Tewari","year":"2016","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"10.1016\/j.humpath.2020.04.012_bib37","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s00534-006-1142-0","article-title":"Predictors of hepatic venous trunk invasion and prognostic factors in patients with hepatocellular carcinomas that had come into contact with the trunk of major hepatic veins","volume":"14","author":"Matsuda","year":"2007","journal-title":"J Hepatobiliary Pancreat Surg"},{"key":"10.1016\/j.humpath.2020.04.012_bib38","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/modpathol.3800726","article-title":"Renal veins and venous extension in clear cell renal cell carcinoma","volume":"20","author":"Bonsib","year":"2007","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2020.04.012_bib39","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1067\/msy.2001.118373","article-title":"Iatrogenic pheochromocytomatosis: a previously unreported result of laparoscopic adrenalectomy","volume":"130","author":"Li","year":"2001","journal-title":"Surgery"},{"key":"10.1016\/j.humpath.2020.04.012_bib40","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.surg.2008.02.007","article-title":"Prognostic indicators of malignancy in adrenal pheochromocytomas: clinical, histopathologic, and cell cycle\/apoptosis gene expression analysis","volume":"143","author":"Strong","year":"2008","journal-title":"Surgery"},{"key":"10.1016\/j.humpath.2020.04.012_bib41","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.ccell.2017.01.001","article-title":"Comprehensive Molecular Characterization of Pheochromocytoma and Paraganglioma","volume":"31","author":"Fishbein","year":"2017","journal-title":"Cancer Cell"},{"key":"10.1016\/j.humpath.2020.04.012_bib42","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.anndiagpath.2013.05.005","article-title":"Are we counting mitoses correctly?","volume":"17","author":"Yigit","year":"2013","journal-title":"Ann Diagn Pathol"},{"key":"10.1016\/j.humpath.2020.04.012_bib43","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1038\/s41379-018-0110-y","article-title":"A common classification framework for neuroendocrine neoplasms: an International Agency for Research on Cancer (IARC) and World Health Organization (WHO) expert consensus proposal","volume":"31","author":"Rindi","year":"2018","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2020.04.012_bib44","doi-asserted-by":"crossref","first-page":"280","DOI":"10.3390\/jcm7090280","article-title":"The Diagnosis and Clinical Significance of Paragangliomas in Unusual Locations","volume":"7","author":"Asa","year":"2018","journal-title":"J Clin Med"},{"key":"10.1016\/j.humpath.2020.04.012_bib45","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1136\/jclinpath-2016-203830","article-title":"Extranodal extension of lymph node metastasis is a marker of poor prognosis in oesophageal cancer: a systematic review with meta-analysis","volume":"69","author":"Luchini","year":"2016","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.humpath.2020.04.012_bib46","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.3349\/ymj.2016.57.6.1324","article-title":"Prognostic Value of Extranodal Extension in Thyroid Cancer: A Meta-Analysis","volume":"57","author":"Suh","year":"2016","journal-title":"Yonsei Med J"},{"key":"10.1016\/j.humpath.2020.04.012_bib47","doi-asserted-by":"crossref","first-page":"61393","DOI":"10.18632\/oncotarget.18223","article-title":"Extranodal extension status is a powerful prognostic factor in stage III colorectal cancer","volume":"8","author":"Kim","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.humpath.2020.04.012_bib48","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1186\/s12885-018-4851-2","article-title":"Lymphovascular invasion and extranodal tumour extension are risk indicators of breast cancer related lymphoedema: an observational retrospective study with long-term follow-up","volume":"18","author":"Invernizzi","year":"2018","journal-title":"BMC Cancer"},{"key":"10.1016\/j.humpath.2020.04.012_bib49","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.otorri.2017.07.002","article-title":"Prognostic significance of extranodal extension in head and neck squamous cell carcinoma cN0 patients with occult metastatic neck nodes","volume":"69","author":"Lop","year":"2018","journal-title":"Acta Otorrinolaringol Esp"},{"key":"10.1016\/j.humpath.2020.04.012_bib50","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1007\/s00428-018-2309-1","article-title":"Extranodal extension of nodal metastases is a poor prognostic moderator in non-small cell lung cancer: a meta-analysis","volume":"472","author":"Luchini","year":"2018","journal-title":"Virchows Arch"},{"key":"10.1016\/j.humpath.2020.04.012_bib51","article-title":"Oropharyngeal Squamous Cell Carcinoma in 390 Patients: Analysis of Clinical and Histological Criteria Which Significantly Impact Outcome","author":"Thompson","year":"2019","journal-title":"Head Neck Pathol"},{"key":"10.1016\/j.humpath.2020.04.012_bib52","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1097\/PAS.0b013e318190d12e","article-title":"Observer variation in the application of the Pheochromocytoma of the Adrenal Gland Scaled Score","volume":"33","author":"Wu","year":"2009","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2020.04.012_bib53","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11020225","article-title":"The Value of Histological Algorithms to Predict the Malignancy Potential of Pheochromocytomas and Abdominal Paragangliomas-A Meta-Analysis and Systematic Review of the Literature","volume":"11","author":"Stenman","year":"2019","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.humpath.2020.04.012_bib54","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1097\/SLA.0000000000000283","article-title":"The presence of SDHB mutations should modify surgical indications for carotid body paragangliomas","volume":"260","author":"Ellis","year":"2014","journal-title":"Ann Surg"},{"key":"10.1016\/j.humpath.2020.04.012_bib55","doi-asserted-by":"crossref","DOI":"10.3390\/jcm7090242","article-title":"Risk Stratification on Pheochromocytoma and Paraganglioma from Laboratory and Clinical Medicine","volume":"7","author":"Kimura","year":"2018","journal-title":"J Clin Med"},{"key":"10.1016\/j.humpath.2020.04.012_bib56","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1002\/cncy.21765","article-title":"Algorithmic approach to neuroendocrine tumors in targeted biopsies: Practical applications of immunohistochemical markers","volume":"124","author":"Duan","year":"2016","journal-title":"Cancer Cytopathol"},{"key":"10.1016\/j.humpath.2020.04.012_bib57","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1097\/PAS.0000000000001037","article-title":"INSM1 is a Sensitive and Specific Marker of Neuroendocrine Differentiation in Head and Neck Tumors","volume":"42","author":"Rooper","year":"2018","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2020.04.012_bib58","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/PAS.0b013e3182a0218f","article-title":"GATA3: a multispecific but potentially useful marker in surgical pathology: a systematic analysis of 2500 epithelial and nonepithelial tumors","volume":"38","author":"Miettinen","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2020.04.012_bib59","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/BF01607135","article-title":"Catecholamine synthesizing enzymes in 70 cases of functioning and non-functioning phaeochromocytoma and extra-adrenal paraganglioma","volume":"421","author":"Kimura","year":"1992","journal-title":"Virchows Arch A Pathol Anat Histopathol"},{"key":"10.1016\/j.humpath.2020.04.012_bib60","first-page":"429","article-title":"A comparative immunohistochemical study of phaeochromocytomas and paragangliomas","volume":"8","author":"Fraga","year":"1993","journal-title":"Histol Histopathol"},{"key":"10.1016\/j.humpath.2020.04.012_bib61","first-page":"591","article-title":"Abstract #596: Alpha-inhibin Expression in Paragangliomas and Pheochromocytomas Shows Strong Correlation with VHL- and SDHx-driven Pseudohypoxic Pathway Disease","volume":"33","author":"Pakbaz","year":"2020","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2020.04.012_bib62","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1097\/00000478-198706000-00009","article-title":"Lipid degeneration in pheochromocytomas mimicking adrenal cortical tumors","volume":"11","author":"Ramsay","year":"1987","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2020.04.012_bib63","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0002-9440(10)65563-0","article-title":"Multiple neuroendocrine tumors of the pancreas in von Hippel-Lindau disease patients: histopathological and molecular genetic analysis","volume":"153","author":"Lubensky","year":"1998","journal-title":"Am J Pathol"},{"key":"10.1016\/j.humpath.2020.04.012_bib64","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1159\/000377703","article-title":"Catecholamine-Synthesizing Enzymes Are Expressed in Parasympathetic Head and Neck Paraganglioma Tissue","volume":"101","author":"Osinga","year":"2015","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.humpath.2020.04.012_bib65","doi-asserted-by":"crossref","DOI":"10.1007\/s12022-020-09618-1","article-title":"The Diagnostic Dilemma of GATA3 Immunohistochemistry in Pheochromocytoma and Paraganglioma","author":"Kimura","year":"2020","journal-title":"Endocr Pathol"},{"key":"10.1016\/j.humpath.2020.04.012_bib66","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.humpath.2009.12.005","article-title":"Immunohistochemistry for SDHB triages genetic testing of SDHB, SDHC, and SDHD in paraganglioma-pheochromocytoma syndromes","volume":"41","author":"Gill","year":"2010","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2020.04.012_bib67","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1111\/apm.12269","article-title":"Usefulness of Succinate dehydrogenase B (SDHB) immunohistochemistry in guiding mutational screening among patients with pheochromocytoma-paraganglioma syndromes","volume":"122","author":"Pai","year":"2014","journal-title":"APMIS"},{"key":"10.1016\/j.humpath.2020.04.012_bib68","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.humpath.2017.10.013","article-title":"The utility of SDHB and FH immunohistochemistry in patients evaluated for hereditary paraganglioma-pheochromocytoma syndromes","volume":"71","author":"Udager","year":"2018","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2020.04.012_bib69","doi-asserted-by":"crossref","first-page":"805","DOI":"10.21873\/anticanres.11381","article-title":"Potential Pitfalls of SDH Immunohistochemical Detection in Paragangliomas and Phaeochromocytomas Harbouring Germline SDHx Gene Mutation","volume":"37","author":"Santi","year":"2017","journal-title":"Anticancer Res"},{"key":"10.1016\/j.humpath.2020.04.012_bib70","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1053\/j.semdp.2013.06.006","article-title":"Paragangliomas: update on differential diagnostic considerations, composite tumors, and recent genetic developments","volume":"30","author":"Papathomas","year":"2013","journal-title":"Semin Diagn Pathol"},{"key":"10.1016\/j.humpath.2020.04.012_bib71","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1038\/modpathol.2015.41","article-title":"SDHB\/SDHA immunohistochemistry in pheochromocytomas and paragangliomas: a multicenter interobserver variation analysis using virtual microscopy: a Multinational Study of the European Network for the Study of Adrenal Tumors (ENS@T)","volume":"28","author":"Papathomas","year":"2015","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2020.04.012_bib72","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/S1470-2045(09)70164-0","article-title":"An immunohistochemical procedure to detect patients with paraganglioma and phaeochromocytoma with germline SDHB, SDHC, or SDHD gene mutations: a retrospective and prospective analysis","volume":"10","author":"van Nederveen","year":"2009","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.humpath.2020.04.012_bib73","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1136\/jmedgenet-2015-103218","article-title":"Recommendations for somatic and germline genetic testing of single pheochromocytoma and paraganglioma based on findings from a series of 329 patients","volume":"52","author":"Curras-Freixes","year":"2015","journal-title":"J Med Genet"},{"key":"10.1016\/j.humpath.2020.04.012_bib74","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1038\/s41436-018-0106-5","article-title":"Metabolome-guided genomics to identify pathogenic variants in isocitrate dehydrogenase, fumarate hydratase, and succinate dehydrogenase genes in pheochromocytoma and paraganglioma","volume":"21","author":"Richter","year":"2019","journal-title":"Genet Med"},{"key":"10.1016\/j.humpath.2020.04.012_bib75","doi-asserted-by":"crossref","first-page":"2440","DOI":"10.1093\/hmg\/ddt639","article-title":"Germline mutations in FH confer predisposition to malignant pheochromocytomas and paragangliomas","volume":"23","author":"Castro-Vega","year":"2014","journal-title":"Hum Mol Genet"}],"container-title":["Human Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817720300848?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817720300848?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T16:38:50Z","timestamp":1758645530000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0046817720300848"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":75,"alternative-id":["S0046817720300848"],"URL":"https:\/\/doi.org\/10.1016\/j.humpath.2020.04.012","relation":{},"ISSN":["0046-8177"],"issn-type":[{"value":"0046-8177","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Data set for the reporting of pheochromocytoma and paraganglioma: explanations and recommendations of the guidelines from the International Collaboration on Cancer Reporting","name":"articletitle","label":"Article Title"},{"value":"Human Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humpath.2020.04.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}